PROSIT Coronary Heart Disease Models

From Prosit
Revision as of 18:45, 29 January 2018 by Fsailer (talk | contribs) (copy and paste from PROSIT myocardial infarction models page)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search

Button ok.png This page is approved PROSIT Content. It may be edited.

Previously published as PROSIT Myocardial Infarction Models

MissouriB Model

Structure of the PROSIT Myocardial Infarction Diabetes Disease Model Missouri A/B

Latest Release: 11. July 2017

Latest Version: PROSIT CHD Type 2 Diabetes Disease Model 2016B Germany

Summary: New release of the cardiovascular disease model based on a similar methodology as Missouri A that allows to include patient sub-groups. The model is open for discussion: use the discussion link at the top of this page.

Methodology: Markov model (Markov process)

Health Economic Perspective: flexible, dependent on user specification

Time Horizon: 80 cycles; currently defined as annual time steps

Patient Cohort: realistic diabetes cohort for Germany and type 2 diabetes mellitus based on the ProValue study. Divided into up to 16 sub-cohorts. Cohort specifications can be edited freely.

Costs: summary costs for Germany are included based on the KODIM Cost study and results being inflationed to the year 2015. Costs can be edited freely.

Other specifications: the model supports QALYS, and discounting of both costs and effects. The half-cycle correction is implemented as within-cycle correction.

Team Members: Fabian Sailer, Monika Pobiruchin, Wendelin Schramm

Previous Versions: Missouri A

MissouriA Model

Discontinued version Missouri A: Missouri A has been abandoned with the release of the Missouri B model.

Latest Version: PROSIT CHD Type 2 Diabetes Disease Model 2013A Germany RC1

Summary: First release of the Missouri A structure based on a new methodology that allows to include patient sub-groups.

Team Members: Christian Weiß, Kurt Neeser, Jens Attumalil, Wendelin Schramm